Cite
MLA Citation
Yazmin Odia et al.. “CTNI-17. A PHASE 1 WITH DOSE EXPANSION/PHASE 2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA.” Neuro-oncology, vol. 23, 2021, pp. vi62–vi63. http://access.bl.uk/ark:/81055/vdc_100146090361.0x00002d